CE Melphalan is being developed as a novel version of the well-established conditioning treatment in autologous transplant for patients with multiple myeloma. CE Melphalan does not contain propylene ...
ATLANTA, Aug. 15, 2014 -- Avion Pharmaceuticals, LLC, announces the signing of a commercial license agreement withLigand Pharmaceuticals Incorporated (NASDAQ: LGND) for the development and ...
Captisol is an engineered mixture of sulfo-butyl-ether cyclodextrins (SBECD) that is complex to manufacture, especially under proprietary and reproducible large-scale GMP processes. We continue ...
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today highlighted the company’s role in the manufacturing of Veklury ® (remdesivir), Gilead Sciences’ antiviral drug for ...
SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for its proprietary ...
SAN DIEGO and ZUG, Switzerland, July 8, 2019 /PRNewswire/ -- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and SQ Innovation AG today announced that the two companies have entered into long-term, ...
Captisol is in over a dozen FDA approved products with multiple product approvals coming in the next year. These approvals include oral and ophthalmic routes of administration. Proven safe! A team of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results